Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0001104659-23-044843 0001590144 XXXXXXXX LIVE 8 Common Stock, par value $0.001 per share 03/05/2025 false 0001162461 232109108 Cutera, Inc. 3240 Bayshore Blvd Brisbane CA 94005-1021 Stephen Fraidin, Esq. 212-504-6000 Cadwalader, Wickersham & Taft LLP 200 Liberty Street New York NY 10281 0001590144 N Pura Vida Investments, LLC b OO N DE 0.00 0.00 0.00 0.00 0.00 N 0 IA 0001789193 N Efrem Kamen b OO N X1 0.00 0.00 0.00 0.00 0.00 N 0 IN Common Stock, par value $0.001 per share Cutera, Inc. 3240 Bayshore Blvd Brisbane CA 94005-1021 This Amendment No. 8 to Schedule 13D (this "Amendment No. 8") relates to the Schedule 13D filed with the SEC on April 13, 2023 by the Reporting Persons (the "Initial Schedule 13D"), as amended and supplemented by Amendment No. 1 to Schedule 13D ("Amendment No. 1") filed with the SEC on May 10, 2023 by the Reporting Persons, by Amendment No. 2 to Schedule 13D ("Amendment No. 2") filed with the SEC on June 12, 2023 by the Reporting Persons, by Amendment No. 3 to Schedule 13D ("Amendment No. 3") filed with the SEC on July 25, 2023 by the Reporting Persons, by Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed with the SEC on July 31, 2023 by the Reporting Persons, by Amendment No. 5 to Schedule 13D ("Amendment No. 5") filed with the SEC on November 17, 2023 by the Reporting Persons, by Amendment No. 6 to Schedule 13D ("Amendment No. 6") filed with the SEC on November 27, 2023 by the Reporting Persons, and by Amendment No. 7 to Schedule 13D ("Amendment No. 7") filed with the SEC on December 29, 2023 by the Reporting Persons (such Initial Schedule 13D, as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 6 and Amendment No. 7, the "Schedule 13D"), relating to the common stock, par value $0.001 per share (the "Common Stock"), of Cutera, Inc. (the "Issuer"). Except to the extent set forth in this Amendment No. 8, all information disclosed in the Schedule 13D remains unchanged. Capitalized terms used but not otherwise defined in this Amendment No. 8 have the meanings ascribed to them in the Schedule 13D. Percentage beneficial ownership reported herein is based on 20,185,926 shares of Common Stock outstanding as of November 8, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on November 12, 2024. This Amendment No. 8 amends Items 3, 5 and 7 of the Schedule 13D as set forth below and constitutes an exit filing for the Reporting Persons. Item 3 of the Schedule 13D is hereby amended and supplemented to add the following information: "On March 5, 2025 and March 6, 2025, the Reporting Persons sold for the accounts of the Pura Vida Funds an aggregate of 1,126,209 shares of Common Stock for aggregate consideration of $128,625.05 (net of commissions)." Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows: "The information contained in rows 7, 8, 9, 10, 11 and 13 on the cover pages of this Amendment No. 8 is incorporated by reference in its entirety into this Item 5. As of November 8, 2024, the Issuer reported 20,185,926 shares of Common Stock outstanding. As of the date of this filing, the Reporting Persons do not beneficially own any shares of Common Stock. Exhibit 99.9 filed herewith, which is incorporated herein by reference, describes the transactions in the Common Stock that were effected by the Reporting Persons for the benefit of the Pura Vida Funds during the past sixty days. To the best knowledge of the Reporting Persons, and other than as described herein, no one other than the Reporting Persons, or the partners, members, affiliates or shareholders of the Reporting Persons, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, shares of Common Stock reported herein as beneficially owned by the Reporting Persons. As of March 6, 2025, the Reporting Persons ceased to be the beneficial owners of more than five percent of the shares of Common Stock of the Issuer. This Amendment No. 8 constitutes an exit filing of the Reporting Persons." Item 7 of the Schedule 13D is hereby amended and supplemented to add the following exhibit: Exhibit Number Description of Exhibits 99.9 Trading Data Pura Vida Investments, LLC /s/ Efrem Kamen Efrem Kamen, Managing Member 03/07/2025 Efrem Kamen /s/ Efrem Kamen Efrem Kamen 03/07/2025